Login

Ngopi & Career : Company ONE XOX SDN BHD | Ng Kok Heng, CEO, XOX BhdXOX:KLS 00:10:00

Share On Facebook Share On Twitter

Ng Kok Heng is the Group Chief Executive Officer at XOX BHD.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Arlo Sarmiento's Journey: Building Vivant Corporation into a Powerhouse for Progress | Arlo Sarmiento, CEO, Vivant Corporation.
00:10:00
Black Mountain Energy CEO Rhett Bennett on Sale of Half Moon Prospect and Future Exploration in WA | Rhett Bennett, CEO, Black Mountain Energy Ltd.
00:10:00
Cybersecurity Trends: Ransomware, Supply Chain Attacks, and the Evolving Threat Landscape
00:10:00
Andreas Gerward of Stayble Therapeutics on Treatment Methods and Anticipated Q4'24 Data | Andreas Gerward, CEO, Stayble Therapeutic AB.
00:10:00
venture firm investing in companies|Greg McAdoo,General Partner,Bolt
00:10:00
Vision Lithium's Quebec Project: Quick Profit Potential Through Direct Ore Sales
00:10:00
Keys to SaaS Pitch Decks and Fundraising|John Luttig,Principal,Founders Fund
00:10:00
built a community that is committed|Fatima Husain,Co-founder and General Partner,Mastry
00:10:00
A pioneering figure in CRISPR technology, recognized for her outstanding contributions to science and healthcare, shaping the future of biotechnology | Rachel Haurwitz, CEO, Caribou Biosciences Inc.
00:10:00
W.P. Carey’s €120 Million Deal for Bank Pekao Headquarters in Warsaw
00:10:00
Real-Life Financial Success: A Client Story by Hyden Ross | Hyden Ross, Director, Pathway Financial Planners.
00:10:00
SUSE CEO DP van Leeuwen Talks Open Source and Strategic Partnerships with Orange Innovation VP Philippe Ensarguet | Dirk-Peter van Leeuwen ,CEO , SUSE SA.

© 2017 - Neuhu+